Cập nhật pháp chế
31 thg 8, 2026•1 phút đọc
HLB liver cancer drug approval delayed again over cGMP manufacturing issue
FDA issued a Complete Response Letter for HLB’s ribociclib NDA, citing cGMP deficiencies at the Chinese Hengrui manufacturing site.
Cập nhật pháp chế
25 thg 8, 2026•1 phút đọc
FDA Recall: Products Exposed to Improper Temperatures (D-0179-2024)
The FDA has recalled products after CGMP deviations revealed exposure to temperatures outside labeled storage conditions.
Cập nhật pháp chế
24 thg 8, 2026•1 phút đọc
FDA Recall: CGMP Deviations Due to Intermittent Temperature Excursions
The FDA has issued a recall citing CGMP deviations caused by intermittent temperature excursions during storage.
Cập nhật pháp chế
24 thg 8, 2026•1 phút đọc
FDA Recalls Product Due to CGMP Deviations
The FDA has initiated a recall of a product because of deviations from current Good Manufacturing Practices (CGMP).
Cập nhật pháp chế
24 thg 8, 2026•1 phút đọc
FDA Recalls Products Due to Contaminated Excipient from Supplier
The FDA has issued a recall for products manufactured with a contaminated excipient that was previously recalled by the supplier, citing CGMP deviations.
Cập nhật pháp chế
24 thg 8, 2026•1 phút đọc
FDA Recalls Next Advanced Antibacterial Hand Sanitizer Over Methanol Contamination
FDA recalls Next Advanced Antibacterial Hand Sanitizer due to ethanol below label claim and methanol contamination; related products from the same plant also withdrawn.